Martinsried/Munich – 5 April, 2007. MediGene AG, (Frankfurt, Prime Standard: MDG), through its wholly owned UK subsidiary in Oxford (formerly Avidex), today announced a funded collaborative research program with the Juvenile Diabetes Research Foundation (JDRF).
